{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:30:24Z","timestamp":1762018224895,"version":"build-2065373602"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ecl.2019.08.010","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T18:12:52Z","timestamp":1571854372000},"page":"811-828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Resistant Hypertension"],"prefix":"10.1016","volume":"48","author":[{"given":"Fady","family":"Hannah-Shmouni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriram","family":"Gubbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. David","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ecl.2019.08.010_bib1","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.ecl.2019.08.010_bib2","first-page":"e426","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.010_bib3","first-page":"e29","article-title":"Heart disease and stroke statistics--2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ecl.2019.08.010_bib4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/HYPERTENSIONAHA.116.08411","article-title":"Resistant hypertension: is the number of drugs a reliable marker of resistance?","volume":"68","author":"Burnier","year":"2016","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.010_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMcp041698","article-title":"Clinical practice. Resistant or difficult-to-control hypertension","volume":"355","author":"Moser","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.ecl.2019.08.010_bib6","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ecl.2019.08.010_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/jhh.2013.140","article-title":"Apparent and true resistant hypertension: definition, prevalence and outcomes","volume":"28","author":"Judd","year":"2014","journal-title":"J\u00a0Hum Hypertens"},{"issue":"12","key":"10.1016\/j.ecl.2019.08.010_bib8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1524-6175.2007.07418.x","article-title":"Masked hypertension definition, impact, outcomes: a critical review","volume":"9","author":"Papadopoulos","year":"2007","journal-title":"J\u00a0Clin Hypertens"},{"issue":"6","key":"10.1016\/j.ecl.2019.08.010_bib9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/HYPERTENSIONAHA.113.01275","article-title":"White-coat hypertension: new insights from recent studies","volume":"62","author":"Franklin","year":"2013","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.010_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1751-7176.2011.00556.x","article-title":"Refractory hypertension: definition, prevalence, and patient characteristics","volume":"14","author":"Acelajado","year":"2012","journal-title":"J\u00a0Clin Hypertens"},{"issue":"12","key":"10.1016\/j.ecl.2019.08.010_bib11","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.amjmed.2016.08.032","article-title":"Isolated systolic hypertension: an update after SPRINT","volume":"129","author":"Bavishi","year":"2016","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.010_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ajh\/hpv058","article-title":"Is isolated nocturnal hypertension a reproducible phenotype?","volume":"29","author":"Abdalla","year":"2016","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib13","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2019.08.010_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.mayocp.2013.06.017","article-title":"Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system","volume":"88","author":"Sim","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.010_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ajh\/hpu151","article-title":"Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations","volume":"28","author":"Achelrod","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ecl.2019.08.010_bib16","doi-asserted-by":"crossref","first-page":"j3984","DOI":"10.1136\/bmj.j3984","article-title":"Trends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995-2015","volume":"358","author":"Sinnott","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.010_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/157340211001141111144219","article-title":"Sleep apnea: an underestimated cause of resistant hypertension","volume":"10","author":"de Abreu-Silva","year":"2014","journal-title":"Curr Hypertens Rev"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.010_bib18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.HYP.0000116223.97436.e5","article-title":"Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"issue":"22","key":"10.1016\/j.ecl.2019.08.010_bib19","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ecl.2019.08.010_bib21","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1681\/ASN.2014040371","article-title":"Commentary on the 2014 BP guidelines from the panel appointed to the Eighth Joint National Committee (JNC 8)","volume":"25","author":"Reisin","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"year":"2011","series-title":"Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34 [Internet]","author":"National Clinical Guideline Centre (UK)","key":"10.1016\/j.ecl.2019.08.010_bib22"},{"issue":"7","key":"10.1016\/j.ecl.2019.08.010_bib23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J\u00a0Hypertens"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.010_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jch.12237","article-title":"Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension","volume":"16","author":"Weber","year":"2014","journal-title":"J\u00a0Clin Hypertens"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib25","first-page":"549","article-title":"The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"31","author":"Daskalopoulou","year":"2015","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1016\/j.ecl.2019.08.010_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/01.HYP.0000038733.08436.98","article-title":"Masked hypertension","volume":"40","author":"Pickering","year":"2002","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.010_bib27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2005.03.070","article-title":"Prognosis of \"masked\" hypertension and \"white-coat\" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study","volume":"46","author":"Ohkubo","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib28","first-page":"580","article-title":"Dilemmas in diagnosing and managing hypertension: is white coat hypertension benign?","volume":"31","author":"Spence","year":"2015","journal-title":"Can J Cardiol"},{"issue":"7","key":"10.1016\/j.ecl.2019.08.010_bib29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41581-018-0006-6","article-title":"Diagnosis and management of resistant hypertension: state of the art","volume":"14","author":"Wei","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ecl.2019.08.010_bib30","series-title":"Endotext","article-title":"Testing for endocrine hypertension","author":"Hannah-Shmouni","year":"2000"},{"key":"10.1016\/j.ecl.2019.08.010_bib31","first-page":"399s","article-title":"Pseudohypertension in the elderly","volume":"4","author":"Spence","year":"1978","journal-title":"Clin Sci Mol Med Suppl"},{"issue":"8","key":"10.1016\/j.ecl.2019.08.010_bib32","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1210\/jc.2015-2800","article-title":"Primary aldosteronism: seismic shifts","volume":"100","author":"Funder","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","article-title":"The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients","volume":"12","author":"Anderson","year":"1994","journal-title":"J\u00a0Hypertens"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.010_bib34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11154-016-9394-8","article-title":"Flushing in (neuro)endocrinology","volume":"17","author":"Hannah-Shmouni","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"issue":"16","key":"10.1016\/j.ecl.2019.08.010_bib35","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.1995.03530160051033","article-title":"The rational clinical examination. Is listening for abdominal bruits useful in the evaluation of hypertension?","volume":"274","author":"Turnbull","year":"1995","journal-title":"JAMA"},{"issue":"8917","key":"10.1016\/j.ecl.2019.08.010_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(94)93002-3","article-title":"Renal artery stenosis and hypertension","volume":"344","author":"Derkx","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.010_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/HYPERTENSIONAHA.116.07433","article-title":"Telling tails: very high plasma renin levels prompt the diagnosis of renal artery stenosis, despite initial negative imaging","volume":"68","author":"Petruzzelli","year":"2016","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.ecl.2019.08.010_bib38","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/ajh\/hpu113","article-title":"Clinical value of plasma renin estimation in the management of hypertension","volume":"27","author":"Brown","year":"2014","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051081","article-title":"Genetics of hypertension in African Americans and others of African descent","volume":"20","author":"Zilbermint","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib40","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement","volume":"55","author":"Campbell","year":"2009","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.010_bib41","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","article-title":"Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity","volume":"51","author":"Schwartz","year":"2005","journal-title":"Clin Chem"},{"issue":"10 Pt 1","key":"10.1016\/j.ecl.2019.08.010_bib42","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","article-title":"High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives","volume":"15","author":"Rossi","year":"2002","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.010_bib43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/jc.2018-01197","article-title":"Clinical, biochemical, and genetic characteristics of \"nonclassic\" apparent mineralocorticoid excess syndrome","volume":"104","author":"Tapia-Castillo","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2019.08.010_bib44","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ecl.2019.08.010_bib45","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.010_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020546","article-title":"The low-renin hypertension phenotype: genetics and the role of the mineralocorticoid receptor","volume":"19","author":"Baudrand","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.010_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-82-1-27","article-title":"Stimulated renin: a screening test for hypertension","volume":"82","author":"Wallach","year":"1975","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/2047487318823575","article-title":"Hypertension in Africa","volume":"26","author":"Spence","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib49","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.2016.8360","article-title":"Cortisol in the evaluation of adrenal insufficiency","volume":"316","author":"Hannah-Shmouni","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ecl.2019.08.010_bib51","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","article-title":"Laboratory evaluation of pheochromocytoma and paraganglioma","volume":"60","author":"Eisenhofer","year":"2014","journal-title":"Clin Chem"},{"issue":"7\u20138","key":"10.1016\/j.ecl.2019.08.010_bib52","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.cca.2010.01.012","article-title":"Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma","volume":"411","author":"Peaston","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.ecl.2019.08.010_bib53","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.010_bib54","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2017.5926","article-title":"Metanephrines for evaluating palpitations and flushing","volume":"318","author":"Hannah-Shmouni","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.010_bib55","first-page":"e38","article-title":"Heart disease and stroke statistics--2016 update: a report from the American Heart Association","volume":"133","author":"Writing Group","year":"2016","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2019.08.010_bib56","first-page":"3","article-title":"Epidemiology of hypertension from childhood to young adulthood in black, white, and Hispanic population samples","volume":"111","author":"Berenson","year":"1996","journal-title":"Public Health Rep"},{"issue":"7","key":"10.1016\/j.ecl.2019.08.010_bib57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0895-7061(95)00116-7","article-title":"Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study","volume":"8","author":"Bao","year":"1995","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.ecl.2019.08.010_bib58","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/HYPERTENSIONAHA.110.168005","article-title":"Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis","volume":"57","author":"Carson","year":"2011","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ecl.2019.08.010_bib59","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ecl.2019.08.010_bib60","doi-asserted-by":"crossref","first-page":"e0127382","DOI":"10.1371\/journal.pone.0127382","article-title":"Prevalence, awareness, treatment and influence of socioeconomic variables on control of high blood pressure: results of the ELSA-Brasil study","volume":"10","author":"Chor","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ecl.2019.08.010_bib61","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.amjhyper.2007.05.013","article-title":"Heritability of arterial stiffness in black and white American youth and young adults","volume":"20","author":"Ge","year":"2007","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.010_bib62","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.amjhyper.2006.10.001","article-title":"A\u00a0whole genome scan for pulse pressure\/stroke volume ratio in African Americans: the HyperGEN study","volume":"20","author":"Sherva","year":"2007","journal-title":"Am J Hypertens"},{"issue":"12","key":"10.1016\/j.ecl.2019.08.010_bib63","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.amjhyper.2007.09.002","article-title":"Beta-adrenergic receptor genes are associated with arterial stiffness in black and white adults: the Bogalusa Heart Study","volume":"20","author":"Chen","year":"2007","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.010_bib64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/HYPERTENSIONAHA.118.11014","article-title":"Age-related blood pressure sensitivity to aldosterone in blacks and whites","volume":"72","author":"Tu","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.010_bib65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/HYPERTENSIONAHA.118.11064","article-title":"Hypertension in blacks: individualized therapy based on renin\/aldosterone phenotyping","volume":"72","author":"Spence","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.010_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.115.06562","article-title":"J\u00a0curve and cuff artefact, and diagnostic inertia in resistant hypertension","volume":"67","author":"Spence","year":"2016","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib67","first-page":"593","article-title":"Blood pressure control in Canada: the view from a stroke prevention clinic","volume":"31","author":"Spence","year":"2015","journal-title":"Can J Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2019.08.010_bib68","first-page":"S38","article-title":"Sodium kinetics in white and black normotensive subjects: possible relevance to salt-sensitive hypertension","volume":"307","author":"Brier","year":"1994","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib69","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.CIR.38.5.965","article-title":"Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosternosm","volume":"38","author":"Helmer","year":"1968","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.010_bib70","first-page":"350","article-title":"The prevalence of salt sensitivity in an African-American adolescent population","volume":"9","author":"Wilson","year":"1999","journal-title":"Ethn Dis"},{"issue":"6","key":"10.1016\/j.ecl.2019.08.010_bib71","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/HYPERTENSIONAHA.113.02989","article-title":"Racial differences in sensitivity of blood pressure to aldosterone","volume":"63","author":"Tu","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ecl.2019.08.010_bib72","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jpeds.2009.02.029","article-title":"Blood aldosterone-to-renin ratio, ambulatory blood pressure, and left ventricular mass in children","volume":"155","author":"Li","year":"2009","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib73","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.HYP.1.5.468","article-title":"Pathophysiology of hypertension in blacks and whites. A review of the basis of racial blood pressure differences","volume":"1","author":"Gillum","year":"1979","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.010_bib74","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cen.13741","article-title":"Diagnostic approach to low-renin hypertension","volume":"89","author":"Monticone","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.ecl.2019.08.010_bib75","first-page":"594","article-title":"Screening for primary aldosteronism--normal ranges for aldosterone and renin in three South African population groups","volume":"91","author":"Rayner","year":"2001","journal-title":"S\u00a0Afr Med J"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib76","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/jhh.2015.88","article-title":"Plasma renin and cardiovascular responses to the cold pressor test differ in black and white populations: The SABPA study","volume":"30","author":"Gafane","year":"2016","journal-title":"J\u00a0Hum Hypertens"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.010_bib77","article-title":"Quantification of systemic renin-angiotensin system peptides of hypertensive black and white African men established from the RAS-Fingerprint(R)","volume":"17","author":"van Rooyen","year":"2016","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib78","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00004872-200305000-00016","article-title":"A\u00a0new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension","volume":"21","author":"Rayner","year":"2003","journal-title":"J\u00a0Hypertens"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.010_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030812","article-title":"Liddle syndrome: review of the literature and description of a new case","volume":"19","author":"Tetti","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ecl.2019.08.010_bib80","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00001648-200301000-00029","article-title":"Salt, slavery and survival- hypertension in the African diaspora","volume":"14","author":"Grim","year":"2003","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib81","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ajh\/hpw167","article-title":"High frequency of variants of candidate genes in black Africans with low renin-resistant hypertension","volume":"30","author":"Jones","year":"2017","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.1016\/j.ecl.2019.08.010_bib82","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ecl.2019.08.010_bib83","doi-asserted-by":"crossref","first-page":"E900","DOI":"10.1210\/jc.2014-4167","article-title":"Primary aldosteronism and ARMC5 variants","volume":"100","author":"Zilbermint","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11 Pt 1","key":"10.1016\/j.ecl.2019.08.010_bib84","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0895-7061(99)00154-5","article-title":"Physiologic tailoring of therapy for resistant hypertension: 20 years' experience with stimulated renin profiling","volume":"12","author":"Spence","year":"1999","journal-title":"Am J Hypertens"},{"issue":"1 Suppl","key":"10.1016\/j.ecl.2019.08.010_bib85","first-page":"I122","article-title":"Biohistory of slavery and blood pressure differences in blacks today. A hypothesis","volume":"17","author":"Wilson","year":"1991","journal-title":"Hypertension"},{"issue":"5930","key":"10.1016\/j.ecl.2019.08.010_bib86","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1126\/science.1172257","article-title":"The genetic structure and history of Africans and African Americans","volume":"324","author":"Tishkoff","year":"2009","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.ecl.2019.08.010_bib87","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1097\/HJH.0000000000001489","article-title":"Hypertension among US-born and foreign-born non-Hispanic blacks: National Health and Nutrition Examination Survey 2003-2014 data","volume":"35","author":"Brown","year":"2017","journal-title":"J\u00a0Hypertens"},{"issue":"12","key":"10.1016\/j.ecl.2019.08.010_bib88","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1097\/HJH.0000000000001501","article-title":"Hypertension in US-born vs. foreign-born African-Americans","volume":"35","author":"Spence","year":"2017","journal-title":"J\u00a0Hypertens"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.010_bib89","first-page":"S259","article-title":"Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma","volume":"2","author":"Biglieri","year":"1984","journal-title":"J\u00a0Hypertens Suppl"},{"issue":"5","key":"10.1016\/j.ecl.2019.08.010_bib90","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/jcem-58-5-783","article-title":"Primary adrenal hyperplasia: a new subset of primary hyperaldosteronism","volume":"58","author":"Banks","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2019.08.010_bib91","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1097\/00004872-200410000-00030","article-title":"The current epidemic of primary aldosteronism: causes and consequences","volume":"22","author":"Spence","year":"2004","journal-title":"J\u00a0Hypertens"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.010_bib92","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/HYPERTENSIONAHA.113.02026","article-title":"Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort","volume":"63","author":"Calhoun","year":"2014","journal-title":"Hypertension"},{"issue":"10008","key":"10.1016\/j.ecl.2019.08.010_bib93","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ecl.2019.08.010_bib94","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000179582.42830.1d","article-title":"Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension","volume":"46","author":"Saha","year":"2005","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.ecl.2019.08.010_bib95","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jash.2014.04.011","article-title":"Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans","volume":"8","author":"Laffer","year":"2014","journal-title":"J\u00a0Am Soc Hypertens"},{"issue":"11","key":"10.1016\/j.ecl.2019.08.010_bib96","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1751-7176.2010.00359.x","article-title":"High prevalence of liddle syndrome phenotype among hypertensive US Veterans in Northwest Louisiana","volume":"12","author":"Tapolyai","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"7","key":"10.1016\/j.ecl.2019.08.010_bib97","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ajh.2009.63","article-title":"Plasma renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial","volume":"22","author":"Egan","year":"2009","journal-title":"Am J Hypertens"},{"issue":"9","key":"10.1016\/j.ecl.2019.08.010_bib98","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ajh\/hpx066","article-title":"Physiological phenotyping for personalized therapy of uncontrolled hypertension in Africa","volume":"30","author":"Akintunde","year":"2017","journal-title":"Am J Hypertens"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852919300647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852919300647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:44:53Z","timestamp":1760175893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852919300647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0889852919300647"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2019.08.010","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistant Hypertension","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2019.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}